Composition Novo-Passit:
Composition per 100 ml of the preparation:
active ingredients Novo-Passit:
Novo-Passit liquid extract (obtained from rhizomes with the roots of Valerian officinalis, herb lemon balm, St.
guaifenesin 4.00 g;
auxiliary substances Novo-Passit:
sodium cyclamate 0.50 g,
xanthan gum 0.10 g,
invert sugar syrup 39.73 g,
sodium benzoate 0.35 g,
sodium saccharin mono-hydrate 0.0926 g,
ethanol 96% 7.03 g,
orange flavor 0.05 g,
sodium citrate dihydrate 0.40 g,
malto-dextrin 8.00 g,
propylene glycol 10.00 g,
purified water up to 100 ml.
pharmachologic effect Novo-Passit:
Pharmacotherapeutic group
Herbal sedative Novo-Passit
ATX code: N05CM
pharmachologic effect Novo-Passit:
Combined drug Novo-Passit, the pharmacological activity of which is due to the components of the extract based on medicinal plant materials with a predominantly sedative (sedative) effect and guaifenesin, which has an anxiolytic (anti-anxiety) effect.
Indications Novo-Passit:
Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, distraction.
"Manager's syndrome" (a state of constant mental stress).
Insomnia (mild forms).
Headaches due to nervous tension.
Migraine.
Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).
As a symptomatic remedy for neurocirculatory dystonia and climacteric syndrome.
Itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.
Application during pregnancy and lactation
During pregnancy, the drug is prescribed only for absolute indications if the expected effect for the mother exceeds the possible risk for the fetus.
If it is necessary to use the drug during lactation, breastfeeding should be discontinued.
Contraindications Novo-Passit:
Hypersensitivity to the components of the drug, especially guaifenesin, myasthenia gravis, children under 12 years of age, sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.
Carefully
Acute diseases of the gastrointestinal tract, liver diseases, alcoholism, traumatic brain injury, brain diseases, epilepsy, children over 12 years of age.
Side effects Novo-Passit:
Patients usually tolerate the drug well.
However, in rare cases, allergic reactions, exanthema, dizziness, fatigue, drowsiness, slight muscle weakness, disorders of the gastrointestinal tract (nausea, vomiting, spasms, heartburn, diarrhea, constipation), decreased concentration of attention, which quickly pass after drug withdrawal ...
If these or other side effects appear, you should consult a doctor.
If any of these side effects get worse, or if you notice any other side effects not listed in the instructions, inform your doctor.
Interaction Novo-Passit:
With the simultaneous administration of the drug Novo-Passit® and other drugs, their effect can be enhanced or weakened. Before you start taking the drug concurrently with other drugs, you should consult your doctor.
The drug Novo-Passit enhances the effect of alcohol and other substances that depress the central nervous system.
Medicines used to relax skeletal muscles (central muscle relaxation) may increase the risk of side effects of the drug, primarily muscle weakness.
St. John's wort extract contained in the preparation reduces the effectiveness of hormonal contraception, as well as drugs used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), intended for the treatment of AIDS, cardiovascular diseases, bronchial diseases and prevention of thromboembolism
Therefore, before you start taking Novo-Passit against the background of these drugs, you should consult your doctor.
How to take Novo-Passit:
The drug is taken undiluted or diluted in a little water.
When using a bottle, the dosage of the drug is carried out using a measuring cap.
Inside, for adults and children over 12 years old.
In the absence of other doctor's recommendations, the drug should be taken 5 ml 3 times a day before meals.
After consulting a doctor, it is possible to increase the dose to 10 ml 3 times a day.
If severe fatigue or depression appears, it is necessary to reduce the morning and afternoon dose by 2 times and take 2.5 ml in the morning and afternoon and 5 ml in the evening.
The interval between doses should be 4-6 hours.
In case of nausea, the drug should be taken with meals.
Overdose Novo-Passit:
Overdose is initially manifested by feelings of depression and drowsiness.
Later, these symptoms may be accompanied by nausea, mild muscle weakness, joint pain, and a feeling of heaviness in the stomach.
If symptoms of an overdose appear, the drug should be discontinued.
First aid: gastric lavage.
Treatment is symptomatic.
You need to see a doctor.
Description Novo-Passit:
Syrupy, transparent or slightly turbid liquid from red-brown to brown color, with a characteristic odor.
During storage, a small precipitate is allowed, which dissolves when shaken.
Special instructions
The drug contains ethanol (from 8.9 to 10.4 g per 100 ml). 5 ml of the drug (single dose) contains up to 0.520 g of absolute ethyl alcohol. The content of absolute ethyl alcohol in the maximum single dose of the drug (10 ml) is up to 1.040 g, in the maximum daily dose (30 ml) - up to 3.120 g.
During treatment with the drug, you should not consume alcoholic beverages. While taking Novo-Passita®, especially for patients with fair skin, you should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium).
The drug Novo-Passit is not recommended for use in patients with impaired absorption of glucose and galactose and with congenital fructose intolerance.
If the symptoms of the disease persist or the condition worsens while using the drug for 7 days, as well as in the event of side effects, you should inform your doctor about it.
Indication Novo-Passit:
for patients with diabetes mellitus:
100 ml of the preparation contains 39.73 g of invert sugar syrup. One dose of the drug (5 ml) contains 1.99 g of invert sugar syrup containing 1.4 g of a mixture of glucose and fructose, which corresponds to 0.12 XE (bread units).
Influence on the ability to drive vehicles and mechanisms
During the period of use of the drug, one should refrain from performing potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms). Novo-Passit